A corporate safety failure has left over 50 infants poisoned with botulism from contaminated baby formula that may have been tainted since production began three years ago, exposing how government oversight failed to protect America’s most vulnerable.
Story Snapshot
- ByHeart baby formula outbreak sickens 51 infants across 19 states with botulism poisoning
- FDA warns ALL ByHeart formula produced since 2022 may be contaminated with deadly bacteria
- Company had repeated contamination violations including mold, water leaks, and insects at facilities
- Parents trusted “organic” marketing while regulators allowed dangerous products to remain on shelves
Widespread Contamination Spans Three Years
The FDA expanded its investigation Wednesday to include every case of infant botulism linked to ByHeart formula since the company began production in March 2022. Federal health officials cannot rule out contamination across all product lots, meaning thousands of families unknowingly fed their babies potentially deadly formula.
The outbreak now officially includes 51 infants in 19 states, with California reporting nine cases and Texas following with seven to eight cases.
Federal health officials have expanded an outbreak of infant botulism tied to recalled ByHeart baby formula to include all illnesses reported since the company began production in March 2022.
Read more: https://t.co/ryz33MhBUW pic.twitter.com/wHxlsjxsEB
— ABC News (@ABC) December 11, 2025
Corporate Negligence Masked as Premium Product
ByHeart marketed itself as a premium organic formula company, charging higher prices while operating contaminated facilities. The New York-based manufacturer sold approximately 200,000 cans monthly despite having contamination problems from its first year of operation.
Independent laboratory tests revealed 36 samples from three different lots contained botulism-causing bacteria, yet the company continued selling products to unsuspecting parents who believed they were purchasing superior nutrition for their children.
Regulatory Failures Enabled Ongoing Danger
FDA inspection documents reveal a disturbing pattern of regulatory failures that allowed ByHeart to continue operations despite repeated violations. In 2022, the company recalled five batches after cronobacter contamination.
The FDA issued a warning letter in 2023 detailing required corrective actions that were never properly addressed. A Pennsylvania plant was shut down in 2023 after inspectors discovered mold, water leaks, and insects, yet production continued at other facilities.
Dr. Jennifer Cope, the CDC scientist leading the investigation, confirmed contamination persisted across all production runs and different raw material lots. This systematic failure suggests fundamental problems with the company’s manufacturing processes that regulators should have caught and corrected before dozens of infants were poisoned.
The FDA’s inability to prevent this outbreak demonstrates how bureaucratic oversight fails when corporate profits take priority over consumer safety.
Parents Demand Corporate Accountability
Families affected by this outbreak trusted ByHeart’s marketing claims about natural, gentle formula only to watch their infants suffer from botulism poisoning. Andi Galindo, whose daughter was hospitalized with botulism in December 2023, demanded accountability after learning contamination may have existed from the beginning of production.
Amy Mazziotti expressed relief that her son’s case is finally being recognized as part of the outbreak investigation, validating her instinct that ByHeart caused his illness.
Multiple families have filed federal lawsuits alleging ByHeart sold defective products and acted negligently. These parents face mounting medical bills and emotional trauma while the company continues cooperating with investigations rather than taking full responsibility.
The fact that no deaths occurred doesn’t diminish the corporate irresponsibility that put dozens of infants at risk through contaminated products that should never have reached store shelves.
